Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Michael Liptay and Jeffrey Borgia.
Michael Liptay
Connection Strength
1.279
Jeffrey Borgia
  1. The role of IGF-pathway biomarkers in determining risks, screening, and prognosis in lung cancer. Oncotarget. 2022; 13:393-407.
    View in: PubMed
    Score: 0.180
  2. Circulating histocompatibility antigen (HLA) gene products may help differentiate benign from malignant indeterminate pulmonary lesions. Hum Immunol. 2018 Jul; 79(7):558-563.
    View in: PubMed
    Score: 0.138
  3. Circulating angiogenesis biomarkers are associated with disease progression in lung adenocarcinoma. Ann Thorac Surg. 2014 Dec; 98(6):1968-75; discussion 1975.
    View in: PubMed
    Score: 0.108
  4. Value of circulating insulin-like growth factor-associated proteins for the detection of stage I non-small cell lung cancer. J Thorac Cardiovasc Surg. 2015 Mar; 149(3):727-34.e1-3; discussion 734.
    View in: PubMed
    Score: 0.108
  5. Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodules. J Thorac Oncol. 2013 Jan; 8(1):31-6.
    View in: PubMed
    Score: 0.096
  6. Development of a serum biomarker panel predicting recurrence in stage I non-small cell lung cancer patients. J Thorac Cardiovasc Surg. 2012 Dec; 144(6):1344-50; discussion 1350-1.
    View in: PubMed
    Score: 0.094
  7. A multi-analyte serum test for the detection of non-small cell lung cancer. Br J Cancer. 2010 Oct 12; 103(8):1221-8.
    View in: PubMed
    Score: 0.082
  8. Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of non-small cell lung cancer. Clin Cancer Res. 2010 Jul 01; 16(13):3452-62.
    View in: PubMed
    Score: 0.080
  9. Association Between Rare Germline Variants in Cancer Susceptibility Genes and Lung Cancer Risk. Ann Thorac Surg. 2026 Jul 31.
    View in: PubMed
    Score: 0.061
  10. Microfluidic lung cancer models: Bridging clinical treatment strategies and tumor microenvironment recapitulation. APL Bioeng. 2025 Dec; 9(4):041505.
    View in: PubMed
    Score: 0.059
  11. Exploratory Algorithms to Aid in Risk of Malignancy Prediction for Indeterminate Pulmonary Nodules. Cancers (Basel). 2025 Apr 05; 17(7).
    View in: PubMed
    Score: 0.056
  12. Conditional survival analysis of patients with resected non-small cell lung cancer. JTCVS Open. 2023 Dec; 16:948-959.
    View in: PubMed
    Score: 0.050
  13. Low-Dose Computed Tomography Scan Features Are Associated With Annual Risk of Hospitalization. Ann Thorac Surg Short Rep. 2023 Dec; 1(4):558-561.
    View in: PubMed
    Score: 0.050
  14. The association between thoracic sarcopenia and survival is gender specific in early-stage lung cancer. J Thorac Dis. 2022 Nov; 14(11):4256-4265.
    View in: PubMed
    Score: 0.047
  15. Sarcopenia after induction therapy is associated with reduced survival in patients undergoing esophagectomy for locally-advanced esophageal cancer. J Thorac Dis. 2021 Feb; 13(2):861-869.
    View in: PubMed
    Score: 0.042
  16. Evaluation of Plasma miR-21 and miR-152 as Diagnostic Biomarkers for Common Types of Human Cancers. J Cancer. 2016; 7(5):490-9.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.